In conclusion, our data suggested that dynamic changes between CCR7−CD45RA−CD8+ T cell or CCR7−CD45RA+CD8+ T cell is found in the systemic immunity and shift toward CCR7−CD45RA+CD8+ T cell is associated with tumor progression in the OSCC patients. Here, CD8A is linked to neoplasm.